| scholarly article | Q13442814 |
| P50 | author | Joseph A. Trapani | Q46248485 |
| Constantine S. Tam | Q55445006 | ||
| George J Weiner | Q61983045 | ||
| Paul Neeson | Q41627173 | ||
| P2093 | author name string | Hubert Schrezenmeier | |
| Thomas Simmet | |||
| Bernd Jahrsdörfer | |||
| Magdalena Hagn | |||
| Stefanie Lindner | |||
| Dorit Fabricius | |||
| Thamara Beyer | |||
| Sue E Blackwell | |||
| Stefan Stilgenbauer | |||
| Verena Ebel | |||
| P2860 | cites work | Granzyme B leakage-induced cell death: a new type of activation-induced natural killer cell death. | Q44667094 |
| Apoptotic tumor cells are superior to tumor cell lysate, and tumor cell RNA in induction of autologous T cell response in B-CLL. | Q45073094 | ||
| CD5+ B cells from individuals with systemic lupus erythematosus express granzyme B. | Q45176452 | ||
| Dendritic cells loaded with apoptotic tumour cells induce a stronger T-cell response than dendritic cell-tumour hybrids in B-CLL. | Q45862341 | ||
| Autologous T lymphocytes may specifically recognize leukaemic B cells in patients with chronic lymphocytic leukaemia | Q45873210 | ||
| CD86 and CD80 differentially modulate the suppressive function of human regulatory T cells | Q47192084 | ||
| Distinct activation signals determine whether IL-21 induces B cell costimulation, growth arrest, or Bim-dependent apoptosis | Q47309544 | ||
| Treatment of BXSB-Yaa mice with IL-21R-Fc fusion protein minimally attenuates systemic lupus erythematosus. | Q51976160 | ||
| The Akt signaling pathway determines the different proliferative capacity of chronic lymphocytic leukemia B-cells from patients with progressive and stable disease. | Q53595110 | ||
| Allogeneic dendritic cells pulsed with tumor lysates or apoptotic bodies as immunotherapy for patients with early-stage B-cell chronic lymphocytic leukemia. | Q54656167 | ||
| CD40 triggering of chronic lymphocytic leukemia B cells results in efficient alloantigen presentation and cytotoxic T lymphocyte induction by up-regulation of CD80 and CD86 costimulatory molecules | Q56908513 | ||
| Evidence for involvement of clonally expanded CD8+ T cells in anticancer immune responses in CLL patients following nonmyeloablative conditioning and hematopoietic cell transplantation | Q60635004 | ||
| The chemokine receptor CXCR3 is expressed in a subset of B-cell lymphomas and is a marker of B-cell chronic lymphocytic leukemia | Q73337949 | ||
| CpG DNA increases primary malignant B cell expression of costimulatory molecules and target antigens | Q73492223 | ||
| T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapy | Q74314281 | ||
| IL-21 as new therapy for CLL? | Q81163947 | ||
| B-cell lymphomas differ in their responsiveness to CpG oligodeoxynucleotides | Q81474815 | ||
| Interleukin-21: biology and application to cancer therapy | Q94705788 | ||
| Interleukin 21 and its receptor are involved in NK cell expansion and regulation of lymphocyte function | Q24290522 | ||
| Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. | Q30496008 | ||
| CD40-ligand (CD154) gene therapy for chronic lymphocytic leukemia | Q33334835 | ||
| Granzyme B: pro-apoptotic, antiviral and antitumor functions | Q34263689 | ||
| Perforin and the granule exocytosis cytotoxicity pathway | Q35538157 | ||
| Recent developments in the transcriptional regulation of cytolytic effector cells | Q35934180 | ||
| Phase I clinical trial of CpG oligonucleotide 7909 (PF-03512676) in patients with previously treated chronic lymphocytic leukemia | Q36222910 | ||
| Tumoricidal activity of TLR7/8-activated inflammatory dendritic cells. | Q36229384 | ||
| Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity | Q36375304 | ||
| IL-21 mediates apoptosis through up-regulation of the BH3 family member BIM and enhances both direct and antibody-dependent cellular cytotoxicity in primary chronic lymphocytic leukemia cells in vitro | Q36591370 | ||
| From normal to clonal B cells: Chronic lymphocytic leukemia (CLL) at the crossroad between neoplasia and autoimmunity | Q37012539 | ||
| The paradox of CD5-expressing B cells in systemic lupus erythematosus | Q37012556 | ||
| Immunogenic cancer cell death: a key-lock paradigm | Q37198125 | ||
| Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. | Q37225614 | ||
| IL-21: an executor of B cell fate | Q37388253 | ||
| Immunostimulatory oligodeoxynucleotides induce apoptosis of B cell chronic lymphocytic leukemia cells. | Q38333437 | ||
| Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities. | Q39281392 | ||
| Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells | Q39501063 | ||
| A critical role for granzymes in antigen cross-presentation through regulating phagocytosis of killed tumor cells. | Q39516978 | ||
| Acute lymphoblastic leukemia cells treated with CpG oligodeoxynucleotides, IL-4 and CD40 ligand facilitate enhanced anti-leukemic CTL responses. | Q39551385 | ||
| Monocyte derived dendritic cells generated by IFN-alpha acquire mature dendritic and natural killer cell properties as shown by gene expression analysis | Q39755645 | ||
| Granzyme B: evidence for a role in the origin of myasthenia gravis | Q39954776 | ||
| Interferon-producing killer dendritic cells provide a link between innate and adaptive immunity | Q40323654 | ||
| Good prognosis cytogenetics in B-cell chronic lymphocytic leukemia is associated in vitro with low susceptibility to apoptosis and enhanced immunogenicity | Q40439092 | ||
| Advances in the biology and treatment of B-cell chronic lymphocytic leukemia | Q40563440 | ||
| Apoptotic pancreatic tumor cells are superior to cell lysates in promoting cross-priming of cytotoxic T cells and activate NK and gammadelta T cells. | Q40737940 | ||
| B-chronic lymphocytic leukemia cells and other B cells can produce granzyme B and gain cytotoxic potential after interleukin-21-based activation. | Q42742024 | ||
| IFN-α enhances cross-presentation in human dendritic cells by modulating antigen survival, endocytic routing, and processing. | Q43047480 | ||
| Human B cells secrete granzyme B when recognizing viral antigens in the context of the acute phase cytokine IL-21. | Q43517682 | ||
| Activation-induced cell death of human T-cell subsets is mediated by Fas and granzyme B but is independent of TNF-alpha. | Q43792305 | ||
| P433 | issue | 7 | |
| P921 | main subject | B-cell chronic lymphocytic leukemia | Q11829285 |
| P304 | page(s) | 383-395 | |
| P577 | publication date | 2014-02-04 | |
| P1433 | published in | International Immunology | Q15710043 |
| P1476 | title | B-CLL cells acquire APC- and CTL-like phenotypic characteristics after stimulation with CpG ODN and IL-21 | |
| P478 | volume | 26 |
| Q36140670 | CpG oligodeoxynucleotide CpG-685 upregulates functional interleukin-21 receptor on chronic lymphocytic leukemia B cells through an NF-κB mediated pathway |
| Q36842259 | GIFT4 fusokine converts leukemic B cells into immune helper cells |
| Q38471387 | IL-21: a pleiotropic cytokine with potential applications in oncology |
| Q94476088 | Influence of the Hippo-YAP signalling pathway on tumor associated macrophages (TAMs) and its implications on cancer immunosuppressive microenvironment |
| Q38984569 | Modeling the chronic lymphocytic leukemia microenvironment in vitro |
| Q38911219 | Regulatory B lymphocyte functions should be considered in chronic lymphocytic leukemia |
| Q28078919 | The Biological Effects of IL-21 Signaling on B-Cell-Mediated Responses in Organ Transplantation |
Search more.